Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ

Are We Entering an Age of Expensive Personalised Medicines?

Contributor:  Pharma IQ
Posted:  09/20/2011  12:00:00 AM EDT  | 
0

Rate this Article: (Be the First!)

Since the approval of Pfizer's lung cancer drug Xalkori by the United States Food and Drug Administration (FDA), headlines have been calling into question the future of personalised medicine – and the cost it will bring with it.

Pfizer's own figures suggest the drug will only be of benefit to between 6,500 and 11,000 patients in the United States who are suffering from AKL positive metastatic non-sma...


Leave this field empty
To continue viewing this content please fill out the form below and become an IQ member.
Already an IQ member? Sign in

First Name:  *
Last Name:  *
Job Title:  *
Phone:  *
E-mail:  *
Company:  *
Country:  *
User Name:  *
Password:  *
Confirm Password:  *
Which of the following best describes your area of expertise?



Pharma IQ Contributor:   Pharma IQ


* = required.

Not a member yet? Sign up
User Name:
Password:

Be the first to leave a comment
Sign in or Sign up to post a comment

Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

Advertisement